DUBLIN--(BUSINESS WIRE)--The "Global Therapeutic Plasma Exchange Market By Technique (Centrifugation v/s Membrane Separation), By Indication (Neurological Disorders, Renal Disorders, Hematology ...
• The American Red Cross and Blood Systems Incorporated (BSI) would be the manufacturers of INTERCEPT plasma for treatment of TTP upon FDA approval and could provide INTERCEPT plasma to other blood ...
Some guidelines advocate PLASMA EXCHANGE for patients with acute renal failure caused by MULTIPLE MYELOMA. This treatment filters excess MONOCLONAL LIGHT CHAINS from the circulation, potentially ...
New York, June 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Therapeutic Plasma Exchange Market By Technique, By Indication, By Gender, By End Use, By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback